- As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective?
- What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment of Alzheimer’s disease, and how can PMHNPs stay current with advancements in this rapidly evolving field?
Patient Case Scenario Debate
response detailing your argument for the following: What is the proposed mechanism of action of the medication(s)? Why might this be appropriate for the patients? What are the advantages or disadvantages to your class of medication (options for different administration, length of duration, etc.)?